American Conference Institute (ACI) will be holding a forum on Biotech and Pharma Public-Private Partnerships on October 25-26, 2007 in Washington, D.C.  The conference will provide a framework for overcoming issues that arise in bridging the innovation gap between industry and academia/government.  In particular, ACI's faculty of experts from big pharma, small biotech, NIH and other government agencies, and research institutions will offer presentations on the following topics:

• 
  Valuing early-stage IP in industry/research institution deals.
• Managing critical IP protection and commercialization issues in industry/academia collaborations.
• Licenses with research institutions and the government: Solving the key problems that confront the deal.
• Federally owned IP: Incorporating government R&D collaborations into your partnership strategy.
• Federally funded IP: Assessing the state of and use of it in grants, contracts, cooperative agreements, and the Bayh-Dole Act.
• Foundations and industry: Managing partnerships between them and increasing the sophistication level of the deal.
• Examining new funding alternatives for biopharmaceutical R&D.
• Recognizing, managing, and resolving individual and institutional conflicts of interest.
• Making the collaboration work: Creating and maintaining the good relationship.

The agenda for the Biotech and Pharma Public-Private Partnerships conference can be found here.  A complete brochure for this conference, including an agenda, list of speakers, and registration form can be downloaded here.

The registration fee ranges from $1,395 (government and academic rate) to $1,995 (regular rate).  Those registering on or before August 31, 2007 will receive a $200 discount off the registration fee.  Those interested in registering for the conference can do so here or by calling 1-888-224-2480.

Patent Docs is a media sponsor of ACI's Biotech and Pharma Public-Private Partnerships conference.